A Phase I Dose Finding Study of MB-CART2219.1

Clinical trial NCT07108868 · RECRUITING

Trial details

NCT number: NCT07108868
Sponsor: University Hospital Tuebingen
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma CLL Acute Lymphoblastic Leukemia, Pediatric

Start date: 2025-06-23
Primary completion: 2027-03-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.